The susceptibility of mice to immune-mediated neurologic disease correlates with the degree to which their lymphocytes resist the effects of brain-derived gangliosides

Journal of Immunology

Volumn 161, Issue 6, 1998, Pages 2746-2752

  Irani, David N ^a,b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GANGLIOSIDE; INTERLEUKIN 2;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; DISEASE PREDISPOSITION; IMMUNOPATHOGENESIS; IMMUNOPATHOLOGY; IMMUNOREGULATION; LYMPHOCYTE; MOUSE; NEUROLOGIC DISEASE; NONHUMAN; PARALYSIS; PRIORITY JOURNAL;

ACUTE DISEASE; ALPHAVIRUS INFECTIONS; ANIMALS; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; BRAIN; CELL DIVISION; DISEASE SUSCEPTIBILITY; ENCEPHALITIS, VIRAL; GANGLIOSIDES; GROWTH INHIBITORS; IMMUNOSUPPRESSIVE AGENTS; INTERLEUKIN-2; LYMPHOCYTE ACTIVATION; LYMPHOCYTES; MICE; MICE, INBRED BALB C; MICE, INBRED STRAINS; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; RNA, MESSENGER; SINDBIS VIRUS; TISSUE EXTRACTS;

EID: 0032530745     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Clatch, R. J., R. W. Melvold, S. D. Miller, and H. L. Lipton. 1985. Theiler's murine encephalomyelitis virus (TMEV)-induced demyelinating disease in mice is influenced by the H-2D region: correlation with TMEV-specific delayed-type hypersensitivity. J. Immunol. 135:1408.
2. Kappel, C. A., M. C. Dal Canto, R. W. Melvold, and B. S. Kim. 1991. Hierarchy of effects of the MHC and TCR β-chain genes in susceptibility to Theiler's murine encephalomyelitis virus-induced demyelinating disease. J. Immunol. 147:4322.
3. Blankenhorn, E. P., and S. A. Stranford. 1992. Genetic factors in demyelinating diseases: genes that control demyelination due to experimental allergic encephalomyelitis (EAE) and Theiler's murine encephalomyelitis virus. Reg. Immunol. 4:331.
4. Ando, D. G., J. Clayton, D. Kono, J. L. Urban, and E. E. Sercarz. 1989. Encephalitogenic T cells in the B10.PL model of experimental allergic encephalomyelitis (EAE) are of the Th-1 lymphokine subtype. Cell. Immunol. 124:132.
5. Kuchroo, V. K., C. A. Martin, J. M. Greer, S.-T. Ju, R. A. Sobel, and M. E. Dorf 1993. Cytokines and adhesion molecules contribute to the ability of myelin proteolipid protein-specific T cell clones to mediate experimental allergic encepha lomyelitis. J. Immunol. 151:4371.
6. Baron, J. L., J. A. Madri, N. H. Ruddle, G. Hashim, and C. A. Janeway. 1993 Surface expression of α4 integrin by CD4 T cells is required for their entry into brain parenchyma. J. Exp. Med. 177:57.
7. Sabelko, K. A., K. A. Kelly, M. H. Nahm, A. H. Cross, and J. H. Russell. 1997. Fas and Fas ligand enhance the pathogenesis of experimental allergic encephalomyelitis, but are not essential for immune privilege in the central nervous system. J. Immunol. 159:3096.
8. Irani, D. N., K.-I. Lin, and D. E. Griffin. 1997. Regulation of brain-derived T cells during acute central nervous system inflammation. J. Immunol. 158:2318.
9. Mokhtarian, F., D. Grob, and D. E. Griffin. 1989. Role of the immune response in Sindbis virus-induced paralysis of SJL/J mice. J. Immunol. 143:633.
10. Schmeid, M., H. Breitschopf, R. Gold, H. Zischler, G. Rothe, H. Wekerle, and H. Lassmann. 1993. Apoptosis of T lymphocytes in experimental autoimmune encephalomyelitis: evidence for programmed cell death as a mechanism to control inflammation in the brain. Am. J. Pathol. 143:446.
11. Bonetti, B., J. Pohl, Y.-L. Gao, and C. S. Raine. 1997. Cell death during auto-immune demyelination: effector but not target cells are eliminated by apoptosis. J. Immunol. 159:5733.
12. Oltvai, Z., C. Milliman, and S. J. Korsmeyer. 1993. Bcl-2 heterodimerizes in vivo with a conserved homolog, bax, that accelerates programmed cell death. Cell 74:609.
13. Irani, D. N., K.-I. Lin, and D. E. Griffin. 1996. Brain-derived gangliosides regulate the cytokine production and proliferation of activated T cells. J. Immunol 157:4333.
14. Irani, D. N., and D. E. Griffin. 1991. Isolation of brain parenchymal lymphocytes for flow cytometric analysis: application to acute viral encephalitis. J. Immunol. Methods 139:223.
15. Miyashita, T., S. Krajewski, M. Krajewski, H. G. Wang, H. K. Lin, D. A. Lieberman, B. Hoffman, and J. C. Reed. 1994. Tumor-suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo. Oncogene 9:1799.
16. Waldner, H., R. A. Sobel, E. Howard, and V. K. Kuchroo. 1997. Fas-and FasL- deficient mice are resistant to induction of autoimmune encephalomyelitis. J. Immunol. 159:3100.
17. D'Souza, S. D., B. Bonetti, V. Balasingham, N. R. Cashman, P. A. Troutt, C. S. Raine, and J. P. Antel. 1996. Multiple sclerosis: Fas signaling in oligodendrocyte cell death. J. Exp. Med. 184:2361.
18. Joly, E., L. Mucke, and M. B. A. Oldstone. 1991. Viral persistence in neurons explained by lack of major histocompatibility class I expression. Science 253:1283.
19. Massa, P. T., R. Brinkmann, and V. Ter Meulen. 1987. Inducibility of Ia antigen on astrocytes by murine coronavirus JHM is rat strain-dependent. J. Exp. Med. 166:259.
20. Lampson, L. A., and G. Siegel. 1988. Defining the mechanisms that govern immune acceptance or rejection of neural tissue. Prog. Brain Res. 78:243.
21. Massa, P. T. 1993. Specific suppression of major histocompatibility complex class I and class II genes in astrocytes by brain-enriched gangliosides. J. Exp. Med. 178:1357.
22. Massa, P. T., K. Ozato, and D. E. McFarlin. 1993. Cell type-specific regulation of major histocompatibility complex (MHC) gene expression in astrocytes, oligodendrocytes, and neurons. Glia 8:201.
23. Byrne, M. C., M. Farooq, M. Sbaschnig-Agler, W. T. Norton, and R. W. Ledeen. 1988. Ganglioside content of astroglia and neurons isolated from maturing rat brain: consideration of the source of astroglial gangliosides. Brain Res. 461:87.
24. Dreyfus, H., J. C. Louis, S. Harth, and P. Mandel. 1980. Gangliosides in cultured neurons. Neuroscience 5:1647.
25. Radin, N. S., A. Brenkert, R. C. Arora, O. Z. Sellinger, and A. L. Flangas. 1972. Glial and neuronal localization of cerebroside-metabolizing enzymes. Brain Res. 39:163.
26. Sbaschnig-Agler, M., H. Dreyfus, W. T. Norton, M. Sensenbrenner, M. Farooq, M. C. Byrne, and R. W. Ledeen. 1988. Gangliosides of cultured astroglia. Brain Res. 461:98.
27. Massa, P. T., S. Hirschfeld, B.-Z. Levi, L. A. Quigley, K. Ozato, and D. E. McFarlin. 1992. Expression of major histocompatibility complex (MHC) class I genes in astrocytes correlates with the presence of nuclear factors that bind to constitutive and inducible enhancers. J. Neuroimmunol. 41:35.
28. Kim, S. U., G. Moretto, and D. H. Shin. 1985. Expression of Ia antigens on the surface of human oligodendrocytes and astrocytes in culture. J. Neuroimmunol. 10: 141.
29. Massa, P. T., V. Ter Meulen, and A. Fontana. 1987. Hyperinducibility of Ia antigen on astrocytes correlates with strain-specific susceptibility to experimental autoimmune encephalomyelitis. Proc. Natl. Acad. Sci. USA 84:4219.